a year ago
ITGR
AnalystsBrett FishbinBrett Fishbin's Stock Forecasts
AnalystsBrett Fishbin
Analyst Ranking
Bottom 9%
#4745 out of 5206 analysts
Average Return
-1.54%
Win Rate
49%21 out of 43
Risk vs Reward
Poor
Good
Brett Fishbin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Icu Medical IncICUI | +70.01% | $95.00 | $161.51 | 2024-02-05 - 2025-02-05 | Strong Buy |
Integer Holdings CorpITGR | +41.87% | $99.39 | $141.00 | 2024-02-15 - 2025-02-14 | Strong Buy |
Integer Holdings CorpITGR | +35.10% | $105.37 | $142.35 | 2024-02-05 - 2025-02-05 | Strong Buy |
Icu Medical IncICUI | +33.13% | $112.48 | $149.75 | 2024-02-27 - 2025-02-27 | Strong Buy |
Texas Instruments IncTXN | +29.41% | $162.13 | $209.82 | 2025-04-23 - 2026-03-02 | Strong Buy |
Brett Fishbin Analyst Color
Get additional color on Brett Fishbin's coverage of popular stocks
a year ago
ICUI
a year ago
ITGR
a year ago
ICUI
a year ago
ALC
2 years ago
STE
Brett Fishbin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Solventum CorpSOLV | 2 | Strong Buy | $99.00 | +35.62% | Maintains | 4 days ago |
Icu Medical IncICUI | 8 | Strong Buy | $180.00 | +22.46% | Maintains | 11 days ago |
Livanova PLCLIVN | 1 | Strong Buy | $81.00 | +15.27% | Initiates Coverage On | 2 months ago |
Resmed IncRMD | 9 | Strong Buy | $299.00 | +16.17% | Maintains | 4 months ago |
Integer Holdings CorpITGR | 8 | Strong Buy | $93.00 | +7.71% | Maintains | 4 months ago |
Alcon IncALC | 6 | Strong Buy | $91.00 | +7.46% | Maintains | 4 months ago |
Steris PLCSTE | 3 | Strong Buy | $288.00 | +16.24% | Maintains | 7 months ago |
Inspire Medical Systems IncINSP | 5 | Strong Buy | $197.00 | +203.97% | Maintains | 7 months ago |
Texas Instruments IncTXN | 1 | Strong Buy | $215.00 | +2.47% | Maintains | 10 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.